Grail Investors

17 investors on Angel Roster list Grail in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Hong Kong and China.

Investors are matched on the company name in their portfolio, so companies that share the name Grail can appear together.

Investors listed
17
With verified email
41%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 17 Grail investors

The most complete profiles first. Showing 17 of 17.

  • Christoph WestphalVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 24 more

    Verified email available

  • Rich AldrichVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Andrew PangVerified

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Verified email available

  • David DonabedianVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • John ZhuVerified

    Venture Capital · China

    Health CareWomen FoundedBiotechnologyHealth Diagnostics

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Julie SunderlandVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedChemical

    Portfolio: Denali Therapeutics, Compass Therapeutics, Aledade, Verve Therapeutics and 12 more

    Verified email available

  • Marian NakadaVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Verified email available

  • Vijay MurthyVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Verified email available

  • Asish Xavier

    Venture Capital, Corporate Venture Capital, Investor · United States

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Contact details available

  • Jeanne Bolger

    Venture Capital, Corporate Venture Capital, Investor · United Kingdom

    Series AHealth CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Contact details available

  • Rebecca Zhu

    Venture Capital, Investor · China

    SeedHealth CareWomen FoundedManufacturingBiotechnology

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Barney Han

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Charles Chon

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Lea Hachigian

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Contact details available

  • Reese Yeh

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Tinnie Chau, CFA

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Glen Kacher

    Angel/Individual, Investment Partner · United States

    SeedEarly Stage VentureInvestment ManagementAnalyticsFinTechMedia and Entertainment

    Portfolio: SignalRank Corporation, RealSelf, Grail, GROUNDFLOOR

    Contact details available

Frequently asked questions

How many Grail investors are on Angel Roster?

Angel Roster lists 17 Grail investors. 7 of them (41%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (7) and Corporate Venture Capital Firms (4). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Grail investors invest in?

Among those that list a stage, the most common are Seed (5), Series A (1) and Early Stage Venture (1).

Where are Grail investors based?

Most are based in the United States (9), Hong Kong (2) and China (2).

Which companies have Grail investors backed?

The most-backed portfolio companies among them are Pulmocide (8), Hua Medicine (7), TScan Therapeutics (6), Mainstay Medical (5) and Quantum Surgical (5).

How do I contact Grail investors?

Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.